{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:44:09Z","timestamp":1787755449603,"version":"build-2784847793"},"reference-count":34,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,30]],"date-time":"2023-09-30T00:00:00Z","timestamp":1696032000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI123321"],"award-info":[{"award-number":["AI123321"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI136118"],"award-info":[{"award-number":["AI136118"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI138139"],"award-info":[{"award-number":["AI138139"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI152220"],"award-info":[{"award-number":["AI152220"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016230","name":"Steven and Alexandra Cohen Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016230","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.jbc.2023.105313","type":"journal-article","created":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T06:06:08Z","timestamp":1696399568000},"page":"105313","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Babesia BdFE1 esterase is required for the anti-parasitic activity of the ACE inhibitor fosinopril"],"prefix":"10.1016","volume":"299","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4944-6006","authenticated-orcid":false,"given":"Pratap","family":"Vydyam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9853-0987","authenticated-orcid":false,"given":"Jae-Yeon","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7292-0808","authenticated-orcid":false,"given":"Shalev","family":"Gihaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meenal","family":"Chand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meital","family":"Gewirtz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Thekkiniath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2696-7274","authenticated-orcid":false,"given":"Stefano","family":"Lonardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4591-2595","authenticated-orcid":false,"given":"Joseph C.","family":"Gennaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Choukri","family":"Ben Mamoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2023.105313_bib1","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.3390\/pathogens10091120","article-title":"Treatment of human babesiosis: then and now","volume":"10","author":"Renard","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.jbc.2023.105313_bib2","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1080\/20477724.2021.1989185","article-title":"Global meta-analysis on Babesia infections in human population: prevalence, distribution and species diversity","volume":"116","author":"Karshima","year":"2022","journal-title":"Pathog. Glob. Health"},{"key":"10.1016\/j.jbc.2023.105313_bib3","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1089\/vbz.2015.1792","article-title":"Prevalence of anaplasma phagocytophilum and Babesia microti in Ixodes scapularis from a newly established Lyme disease endemic area, the Thousand Islands region of Ontario, Canada","volume":"15","author":"Werden","year":"2015","journal-title":"Vector Borne Zoonotic Dis."},{"key":"10.1016\/j.jbc.2023.105313_bib4","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00083-18","article-title":"Emerging tick-borne diseases","volume":"33","author":"Madison-Antenucci","year":"2020","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.jbc.2023.105313_bib5","doi-asserted-by":"crossref","first-page":"273","DOI":"10.15585\/mmwr.mm7211a1","article-title":"Trends in reported babesiosis cases United States, 2011\u20132019","volume":"72","author":"Swanson","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jbc.2023.105313_bib6","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1086\/649859","article-title":"Emergence of resistance to azithromycin-atovaquone in immunocompromised patients with Babesia microti infection","volume":"50","author":"Wormser","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jbc.2023.105313_bib7","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1093\/cid\/cix477","article-title":"Clinical and molecular evidence of atovaquone and azithromycin resistance in relapsed Babesia microti infection associated with rituximab and chronic lymphocytic leukemia","volume":"65","author":"Simon","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jbc.2023.105313_bib8","doi-asserted-by":"crossref","first-page":"19974","DOI":"10.1074\/jbc.AC118.005771","article-title":"Establishment of a continuous in\u00a0vitro culture of Babesia duncani in human erythrocytes reveals unusually high tolerance to recommended therapies","volume":"293","author":"Abraham","year":"2018","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2023.105313_bib9","first-page":"853","article-title":"Pathology of acute fatal babesiosis in hamsters experimentally infected with the WA-1 strain of Babesia","volume":"74","author":"Dao","year":"1996","journal-title":"Lab. Invest."},{"key":"10.1016\/j.jbc.2023.105313_bib10","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1093\/infdis\/jiac181","article-title":"Babesia duncani as a model organism to study the development, virulence and drug susceptibility of intraerythrocytic parasites in\u00a0vitro and in\u00a0vivo","volume":"226","author":"Pal","year":"2022","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.jbc.2023.105313_bib11","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2165\/00003495-198800355-00016","article-title":"Safety profiles of the angiotensin-converting enzyme inhibitors","volume":"35 Suppl 5","author":"Warner","year":"1988","journal-title":"Drugs"},{"key":"10.1016\/j.jbc.2023.105313_bib12","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(21)01330-1","article-title":"Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants","volume":"398","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jbc.2023.105313_bib13","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/S0140-6736(20)31131-4","article-title":"Hypertension, renin-angiotensin-aldosterone system inhibition, and COVID-19","volume":"395","author":"Williams","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jbc.2023.105313_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.112.006809","article-title":"A\u00a0modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzyme","volume":"65","author":"Bernstein","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.jbc.2023.105313_bib15","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1084\/jem.103.3.295","article-title":"The preparation and function of the hypertensin-converting enzyme","volume":"103","author":"Skeggs","year":"1956","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.jbc.2023.105313_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.968104","article-title":"Small molecule angiotensin converting enzyme inhibitors: a medicinal chemistry perspective","volume":"13","author":"Zheng","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jbc.2023.105313_bib17","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/j.1552-4604.1991.tb01887.x","article-title":"Pharmacokinetics, safety, and pharmacologic effects of fosinopril sodium, an angiotensin-converting enzyme inhibitor in healthy subjects","volume":"31","author":"Duchin","year":"1991","journal-title":"J.\u00a0Clin. Pharmacol."},{"key":"10.1016\/j.jbc.2023.105313_bib18","first-page":"599","article-title":"An alternative culture medium for continuous in vitro propagation of the human pathogen Babesia duncani in human erythrocytes pathogens","volume":"11","author":"Singh","year":"2022"},{"key":"10.1016\/j.jbc.2023.105313_bib19","article-title":"Babesia duncani in culture and in mouse (ICIM) model for the advancement of Babesia biology, pathogenesis, and therapy","volume":"12","author":"Kumari","year":"2022","journal-title":"Bio Protoc."},{"key":"10.1016\/j.jbc.2023.105313_bib20","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1023\/A:1015823315983","article-title":"Relative lipophilicities and structural-pharmacological considerations of various angiotensin-converting enzyme (ACE) inhibitors","volume":"9","author":"Ranadive","year":"1992","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jbc.2023.105313_bib21","first-page":"123","article-title":"Plasmodium falciparum in\u00a0vitro drug resistance selections and gene editing methods","volume":"2013","author":"Ng","year":"2019","journal-title":"Mol. Biol."},{"key":"10.1016\/j.jbc.2023.105313_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14240","article-title":"Esterase mutation is a mechanism of resistance to antimalarial compounds","volume":"8","author":"Istvan","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2023.105313_bib23","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2165\/00003495-199243010-00009","article-title":"Fosinopril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in essential hypertension","volume":"43","author":"Murdoch","year":"1992","journal-title":"Drugs"},{"key":"10.1016\/j.jbc.2023.105313_bib24","doi-asserted-by":"crossref","first-page":"460","DOI":"10.2165\/00003088-199732060-00003","article-title":"Fosinopril. Clinical pharmacokinetics and clinical potential","volume":"32","author":"Shionoiri","year":"1997","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jbc.2023.105313_bib25","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2165\/00003495-199754010-00012","article-title":"Fosinopril. A review of its pharmacology and clinical efficacy in the management of heart failure","volume":"54","author":"Davis","year":"1997","journal-title":"Drugs"},{"key":"10.1016\/j.jbc.2023.105313_bib26","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/s41564-023-01360-8","article-title":"Babesia duncani multi-omics identifies virulence factors and drug targets","volume":"8","author":"Singh","year":"2023","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.jbc.2023.105313_bib27","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1021\/acsinfecdis.0c00487","article-title":"Resistance to some but not other dimeric lindenane sesquiterpenoid esters is mediated by mutations in a Plasmodium falciparum esterase","volume":"6","author":"Butler","year":"2020","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.jbc.2023.105313_bib28","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02640-19","article-title":"Plasmodium falciparum resistance to a lead benzoxaborole due to blocked compound activation and altered ubiquitination or sumoylation","volume":"11","author":"Sindhe","year":"2020","journal-title":"mBio"},{"key":"10.1016\/j.jbc.2023.105313_bib29","doi-asserted-by":"crossref","first-page":"9102","DOI":"10.1093\/nar\/gks700","article-title":"Sequencing of the smallest Apicomplexan genome from the human pathogen Babesia microti","volume":"40","author":"Cornillot","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jbc.2023.105313_bib30","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s12915-022-01361-9","article-title":"Comparative genomic analysis of Babesia duncani responsible for human babesiosis","volume":"20","author":"Wang","year":"2022","journal-title":"BMC Biol."},{"key":"10.1016\/j.jbc.2023.105313_bib31","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1086\/525852","article-title":"Persistent and relapsing babesiosis in immunocompromised patients","volume":"46","author":"Krause","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jbc.2023.105313_bib32","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00662-21","article-title":"Effective therapy targeting cytochrome bc(1) prevents Babesia erythrocytic development and protects from lethal infection","volume":"65","author":"Chiu","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jbc.2023.105313_bib33","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1084\/jem.20151519","article-title":"Radical cure of experimental babesiosis in immunodeficient mice using a combination of an endochin-like quinolone and atovaquone","volume":"213","author":"Lawres","year":"2016","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.jbc.2023.105313_bib34","article-title":"Tafenoquine-atovaquone combination achieves radical cure and confers sterile immunity in experimental models of human Babesiosis","author":"Vydyam","year":"2023","journal-title":"J. Infect. Dis."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925823023414?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925823023414?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T16:41:07Z","timestamp":1762188067000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925823023414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":34,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S0021925823023414"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2023.105313","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Babesia BdFE1 esterase is required for the anti-parasitic activity of the ACE inhibitor fosinopril","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2023.105313","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"105313"}}